HopeStage
Back to all studies
CompletedNCT00546910

Atomoxetine or placebo for ADHD in children

About this titleRead the official source — NCT00546910
Medication studyAges 6–12Germany
The study in practice

Understand this study

Who was this study for?

This study was for people with ADHD. Listed age limits: 6 years to 12 years. Other eligibility criteria applied.

Listed locations
Berlin and 15 more locationsSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateOctober 2007
Recruitment status
Completed
Enrollment listed in the registry
125
Sponsor
Eli Lilly and Company
Sponsor type
Other organization
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Germany
Age range
From 6 Years to 12 Years
Official registry ID
NCT00546910
Official title
Show the full official title

A Randomized, Double Blind Comparison of the Effects of Atomoxetine Versus Placebo on Neuropsychological Outcomes Across the Day in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) by Use of a Computer Based Continuous Performance Test (cb CPT)

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Berlin · Cologne · Datteln

13 more locations
  • Dorsten
  • Düsseldorf
  • Eberswalde
  • Freiburg im Breisgau
  • Fulda
  • Giessen
  • Hagen
  • Hanover
  • Kehl
  • Mannheim
  • München
  • Solingen
  • Wolfenbüttel

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Eli Lilly and Company.

Did this study involve medication?

Yes. The study involved medication, including Atomoxetine and Placebo.

Who was this study for?

This study was for people with ADHD. Listed age limits: 6 years to 12 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies